Top Class Actions’s website and social media posts use affiliate links. If you make a purchase using such links, we may receive a commission, but it will not result in any additional charges to you. Please review our Affiliate Link Disclosure for more information.
Linda and Ralph Woods have sued Pfizer Inc. over its drug Lipitor, alleging that the statin medication caused Linda Woods to develop type-2 diabetes.
The lawsuit asserts that Lipitor can cause type-2 diabetes, an allegation that has been supported by recent studies. Per the Lipitor lawsuit, the fact that Lipitor and other statins can lead to the development of type-2 diabetes was known to the manufacturers for years. However, the plaintiffs point out that it was not until the U.S. Food & Drug Administration (FDA) mandated changes to Lipitor’s drug information that any mention of this risk was even made.
The prescribing information for Lipitor never included any mention of elevated blood sugar levels until February 2012. Even then, the Lipitor lawsuit contends, the information is evasive. The exact wording holds: “Increases in HbA1c and fasting serum glucose levels have been reported with HMG-CoA reductase inhibitors, including LIPITOR.” The lawsuit contends that this language obscures the risks associated with diabetes, as the prescribing information never mentions diabetes by name.
In type-2 diabetes, the body loses its ability to control the level of sugar in the blood and cells. This condition can cause a host of serious complications, including blindness and nerve damage. This nerve damage can in turn lead to necrosis of extremities, which can require amputation to prevent infection.
According to the Lipitor lawsuit, Linda Woods began taking Lipitor in July 2004 at the direction of her physicians. Woods continued to take Lipitor to lower her cholesterol levels to improve her cardiovascular health up through 2006. In 2005, Woods was diagnosed with type-2 diabetes. At the time, Woods had no knowledge that Lipitor could have been the cause of her illness. The diagnosis means that Woods will need regular medical monitoring for the rest of her life. The Lipitor lawsuit asserts that Woods would have never taken the drug had she been aware of the risk of diabetes associated with it.
The Lipitor lawsuit is formally titled Linda M. Wood, et al. v. Pfizer Inc., Case No. 1:13-cv-01916-KOB, in the U.S. District Court for the Northern District of Alabama, Eastern Division.
Free Help for Women who Took Lipitor & Developed Diabetes
If you’re a woman who took Lipitor, or you know a woman who took Lipitor, and later developed type-2 diabetes, you have legal options. Please visit the Lipitor Diabetes Class Action Lawsuit Investigation. There, you can submit your claim for a free legal review and if it qualifies for legal action, a seasoned Lipitor lawyer will contact you for a free, no-obligation consultation. You will be guided through the litigation process at no out-of-pocket expenses or hidden fees. The Lipitor attorneys working this investigation do not get paid until you do.
Top Class Actions Legal Statement
